Methotrexate treatment for ectopic pregnancy after assisted reproductive technology: A case-control study

2016 ◽  
Vol 44 (6) ◽  
pp. 341-344 ◽  
Author(s):  
A. Ohannessian ◽  
P. Crochet ◽  
B. Courbiere ◽  
A. Gnisci ◽  
A. Agostini
Keyword(s):  
Ectopic Pregnancy ◽  
Assisted Reproductive Technology ◽  
Case Control Study ◽  
Reproductive Technology ◽  
Case Control ◽  
Methotrexate Treatment ◽  
Control Study

Success rate of methotrexate treatment for recurrent vs. primary ectopic pregnancy: a case-control study

2019 ◽  
Vol 40 (4) ◽  
pp. 507-511 ◽  
Author(s):  
Gabriel Levin ◽  
Uri P. Dior ◽  
Asher Shushan ◽  
Ronit Gilad ◽  
Avi Benshushan ◽  
...  
Keyword(s):  
Ectopic Pregnancy ◽  
Success Rate ◽  
Case Control Study ◽  
Case Control ◽  
Methotrexate Treatment ◽  
Control Study

Assisted reproductive technology and breastfeeding outcomes: a case-control study

2015 ◽  
Vol 103 (1) ◽  
pp. 89-94 ◽  
Author(s):  
Antonella Cromi ◽  
Maurizio Serati ◽  
Ilario Candeloro ◽  
Stefano Uccella ◽  
Sara Scandroglio ◽  
...  
Keyword(s):  
Assisted Reproductive Technology ◽  
Case Control Study ◽  
Reproductive Technology ◽  
Case Control ◽  
Control Study

scholarly journals Pregnancies Outcome after Assisted Reproductive Technology: A Multicenter Case Control Study in a Low Income Setting Douala, Cameroon

2021 ◽  
Vol 11 (06) ◽  
pp. 720-731
Author(s):  
Tchente Nguefack Charlotte ◽  
Bourdanne Tekouake Didier ◽  
T. Nana Njamen ◽  
Nda Mefo’o Jean Pierre ◽  
Ekono Michel Roger ◽  
...  
Keyword(s):  
Assisted Reproductive Technology ◽  
Low Income ◽  
Case Control Study ◽  
Reproductive Technology ◽  
Case Control ◽  
Low Income Setting ◽  
Control Study

scholarly journals Interleukin-15 (IL-15) and Anti-C1q Antibodies as Serum Biomarkers for Ectopic Pregnancy and Missed Abortion

2013 ◽  
Vol 2013 ◽  
pp. 1-6 ◽  
Author(s):  
Alexandros Daponte ◽  
Efthimios Deligeoroglou ◽  
Spyros Pournaras ◽  
Christos Hadjichristodoulou ◽  
Antonios Garas ◽  
...  
Keyword(s):  
Ectopic Pregnancy ◽  
Case Control Study ◽  
Statistical Significance ◽  
Serum Levels ◽  
Case Control ◽  
Maternal Serum ◽  
Missed Abortion ◽  
Interleukin 15 ◽  
Immunological Factors ◽  
Control Study

Given the present lack of clinically useful tests for the accurate diagnosis of ectopic pregnancy (EP), there is a need to select out those immunological factors measured in the maternal serum, as potential biomarkers. Our assumption was that C1q/anti-C1q antibody complexes and serum levels of interleukin-15 (IL-15) may play a role in differentiating abortions (MAs) and EPs and normal pregnancies. We assessed whether their measurement could set the diagnosis in a case control study at 6–8 weeks consisting of 60 women with failed early pregnancy (30 EPs, 30 MAs) and 33 women with intrauterine pregnancies. Normal pregnancies contain anti-C1q antibodies more frequently compared to women with failed pregnancies, the lowest levels being found in EPs, but this lacked statistical significance and anti-C1q could not serve as a marker. However EP pregnancies had elevated IL-15 levels that could statistically significantly differentiate them from MAs and IUPs. Furthermore, when assessing IL-15 for the clinically important differentiation between IUP and EP, we found at a cut-off of 16 pg/mL a negative predictive value of 99 with a sensitivity for diagnosing an EP of 92%. According to these results, serum IL-15 is a promising marker differentiating an MA from an EP.

Sexually transmitted diseases as major causes of ectopic pregnancy: results from a large case-control study in France*

1994 ◽  
Vol 62 (2) ◽  
pp. 289-295 ◽  
Author(s):  
Joël Coste ◽  
Bernard Laumon ◽  
Alain Brémond ◽  
Pierrette Collet ◽  
Nadine Job-Spira
Keyword(s):  
Ectopic Pregnancy ◽  
Sexually Transmitted Diseases ◽  
Case Control Study ◽  
Case Control ◽  
Sexually Transmitted ◽  
Control Study ◽  
Large Case
Sign in / Sign up

Export Citation Format

Share Document